AlphaQuest LLC Has $551,000 Stock Position in Sotera Health Company $SHC

AlphaQuest LLC lifted its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 7.5% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 49,590 shares of the company’s stock after buying an additional 3,458 shares during the period. AlphaQuest LLC’s holdings in Sotera Health were worth $551,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of SHC. New York State Teachers Retirement System raised its holdings in shares of Sotera Health by 1.9% during the 1st quarter. New York State Teachers Retirement System now owns 59,273 shares of the company’s stock worth $691,000 after buying an additional 1,100 shares in the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Sotera Health during the 1st quarter worth $266,000. Principal Financial Group Inc. raised its holdings in shares of Sotera Health by 0.3% during the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company’s stock worth $4,109,000 after buying an additional 1,037 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of Sotera Health by 5.7% during the 1st quarter. Victory Capital Management Inc. now owns 57,655 shares of the company’s stock worth $672,000 after buying an additional 3,106 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Sotera Health during the 1st quarter worth $602,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, insider Michael P. Rutz sold 126,611 shares of the company’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the sale, the insider owned 450,204 shares in the company, valued at approximately $7,374,341.52. The trade was a 21.95% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the company’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $120,880,000.00. Following the completion of the sale, the director owned 41,215,301 shares in the company, valued at $622,763,198.11. This trade represents a 16.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 20,126,611 shares of company stock worth $304,273,888. Insiders own 55.12% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Barclays boosted their price target on Sotera Health from $17.00 to $19.00 and gave the stock an “overweight” rating in a report on Thursday, October 2nd. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Sotera Health in a report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $17.20.

Sotera Health Price Performance

Shares of SHC opened at $16.56 on Wednesday. Sotera Health Company has a 12-month low of $9.53 and a 12-month high of $17.15. The business has a 50-day simple moving average of $16.12 and a two-hundred day simple moving average of $13.47. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. The stock has a market cap of $4.70 billion, a PE ratio of 207.03 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The business had revenue of $294.34 million during the quarter, compared to analysts’ expectations of $275.81 million. During the same quarter in the prior year, the firm earned $0.19 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Analysts anticipate that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.